Skip to main content

Want a detailed portfolio tracker?

Vera Therapeutics (VERA) P/E (2021 - 2026)

Vera Therapeutics (VERA) P/E from Jun 30, 2021 to Jul 20, 2026. The TTM Vera Therapeutics (VERA) P/E is -7.45. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Vera Therapeutics (VERA)

YearP/EChange
2026-7.45-39.38%
2025-12.30-28.03%
2024-17.09+190.34%
2023-5.88-23.42%
2022-7.68-80.29%
2021-38.98N/A

Comparison Vera Therapeutics (VERA) P/E with competitors

Vera Therapeutics (VERA) P/E is -7.45.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-101.00%
FGENFibroGen Inc0.24-103.22%
CHRSCoherus Biosciences Inc0.85-111.38%
FBIOFortress Biotech Inc0.95-112.73%
ORMPOramed Pharmaceuticals Inc1.50-120.16%
AGENAgenus Inc3.01-140.37%
INVAInnoviva Inc3.15-142.31%
VXRTVaxart Inc3.55-147.62%
CRMDCorMedix Inc3.63-148.68%
CVACCureVac N.V.4.45-159.64%
GLPGGalapagos NV4.86-165.18%
SRPTSarepta Therapeutics Inc4.88-165.49%
ABEOAbeona Therapeutics Inc5.39-172.27%
ABUSArbutus Biopharma Corp5.60-175.06%
ZVRAZevra Therapeutics Inc5.89-178.98%
SPROSpero Therapeutics Inc6.23-183.55%
CGENCompugen Ltd6.31-184.70%
RIGLRigel Pharmaceuticals6.87-192.19%
SLXNSilexion Therapeutics Corp7.30-197.88%
OMEROmeros Corporation9.26-224.21%
AUPHAurinia Pharmaceuticals Inc9.58-228.58%
PLXProtalix BioTherapeutics Inc10.89-246.10%
ACADAcadia Pharmaceuticals Inc11.73-257.34%
TBPHTheravance Biopharma Inc12.26-264.50%
ADMAAdma Biologics Inc12.42-266.59%
HRMYHarmony Biosciences Holdings Inc13.82-285.40%
SABSSAB Biotherapeutics Inc14.14-289.64%
NAGENiagen Bioscience Inc14.82-298.78%
INCYIncyte Corp15.82-312.26%
REGNRegeneron Pharmaceuticals Inc15.86-312.72%
PBYIPuma Biotechnology Inc17.32-332.29%
CPRXCatalyst Pharmaceuticals Inc17.44-333.95%
EXELExelixis Inc17.54-335.27%
TGTXTG Therapeutics Inc18.97-354.43%
MDXGMimedx Group Inc20.55-375.71%
XOMAXOMA Royalty Corp22.87-406.87%
ARGXArgen X SE24.30-425.97%
CTMXCytomX Therapeutics Inc24.82-432.98%
XOMAOXOMA Royalty Corp25.34-440.01%
HALOHalozyme Therapeutics Inc25.62-443.75%
XOMAPXOMA Royalty Corp25.67-444.37%
VRTXVertex Pharmaceuticals Inc27.99-475.56%
RPRXRoyalty Pharma plc - Class A28.69-484.85%
SLNOSoleno Therapeutics Inc29.02-489.25%
ASNDAscendis Pharma A/S30.09-503.61%
LGNDLigand Pharmaceuticals Inc - Class B37.91-608.60%
APLSApellis Pharmaceuticals Inc39.02-623.48%
BMRNBiomarin Pharmaceutical Inc42.21-666.29%
KRYSKrystal Biotech Inc45.34-708.30%
ONCBeiGene Ltd69.54-1032.91%
PHARPharming Group N.V.75.03-1106.49%
TECHBio-Techne Corp101.96-1467.81%
VCELVericel Corp109.92-1574.63%
ALNYAlnylam Pharmaceuticals Inc117.96-1682.54%
GMABGenmab140.29-1982.05%
TLXTelix Pharmaceuticals Ltd162.15-2275.34%
CORTCorcept Therapeutics Inc212.86-2955.56%